ArticleFrontiers in oncology2022

Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status.

Pia Roering et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.